Eli Lilly Shares Dip Despite Stable Growth in GLP-1 Prescriptions [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Weekly Prescription Trends Mixed According to IQVIA data cited by Morgan Stanley, Mounjaro prescriptions for the week ending April 17, 2026 reached roughly 758,400 total prescriptions and 367,900 new prescriptions, up from 749,500 and 361,700 the previous week. Zepbound recorded 615,300 total prescriptions and 350,600 new prescriptions, compared with 632,500 and 346,400 in the prior week, indicating a slight decline in overall volumes but continued growth in new starts. Broader Portfolio Shows Slight Decline Across its broader GLP-1 lineup—including Mounjaro, Trulicity, Zepbound and Foundayo—total prescriptions came in at 1,503,100 for the week, down 0.3% from 1,508,000 previously. The combined total for Mounjaro, Zepbound and Foundayo reached 1,377,400 prescriptions, also representing a 0.3% week-on-week decline. Despite this, Eli Lilly maintained an approximate 59% share of new prescriptions within the GLP-1 category, unchanged from the prior week. The overall GLP-1 mar
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Why Eli Lilly Stock Flopped on Friday [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Why Eli Lilly Stock Flopped on Friday [Yahoo! Finance]Yahoo! Finance
- Eli Lilly: A Heavyweight Battle Isn't Won In Round 1 [Seeking Alpha]Seeking Alpha
- Eli Lilly Stock Falls. Novo Extends Lead in Weight-Loss Drug Race [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's new GLP-1 pill vs. Wegovy, JPMorgan initiates coverage on Hims [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 4/21/26 - Form 4
- 4/21/26 - Form 4
- 4/21/26 - Form 4
- LLY's page on the SEC website